Work

Hepatitis B Vaccine as a Primary Prevention Strategy for Cancer: Mechanisms, Outcomes and Model Extension

Year: 2026
Type: article
Abstract: Vaccination against Hepatitis B can prevent liver cancer by preventing chronic infection of the liver. This paper reviews the role of hepatitis B virus (HBV) in hepatocellular carcinoma, cancer prevention via vaccination, and lessons learned from China's experience for other cancer-prevention programmes. HBV promotes cancer by inducing chronic inflammation in the host, integrating viral DNA into the host's DNA, and altering cell regulation through viral proteins. China's childhood vaccination programme has reduced infections among young children significantly. Extended data from the Qidong trial have also indicated a decrease in primary liver cancer; however, due to a small number of cancer cases, the exact extent remains unknown. Comparison with human papillomavirus (HPV) vaccination shows that the biological principle can be applied to infections, but delivery needs to match the age and circumstances of the target population. China's addition of HPV vaccination to the national programme in 2025 is a policy change. Disease spread can be effectively prevented through timely vaccination, accessible medical services, and ongoing care for high-risk groups.
Author: Qingyang Xia
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7235276736
FWCI:
Cites: 11
Cited by:
Related to: 10